![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current REPL market cap is 522.03M. The company's latest EPS is USD -3.5137 and P/E is -2.42.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -53M | -55.65M | -63.83M | -56.54M | -58.76M |
Net Income | -49.24M | -49.56M | -60.04M | -51.12M | -55.08M |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -56.2M | -79.96M | -118.31M | -177.08M | -234.77M |
Net Income | -52.63M | -80.87M | -118.04M | -174.28M | -215.79M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 646.59M | 603.89M | 562.4M | 532.93M | 487.72M |
Total Liabilities | 91.3M | 89.86M | 97.23M | 111.39M | 113.21M |
Total Equity | 555.29M | 514.03M | 465.17M | 421.54M | 374.51M |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 234.1M | 543.1M | 461.19M | 646.59M | 487.72M |
Total Liabilities | 50.38M | 44.37M | 49.96M | 91.3M | 113.21M |
Total Equity | 183.72M | 498.73M | 411.23M | 555.29M | 374.51M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -128.05M | -48.59M | -92.18M | -139.3M | -185.47M |
Investing | -142.5M | 7.36M | 20.04M | 74M | 97.2M |
Financing | 311.3M | 1.11M | 1.54M | 16.41M | 16.28M |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -60.55M | -61.39M | -82.18M | -128.05M | -185.47M |
Investing | -5.23M | -188.78M | -1.81M | -142.5M | 97.2M |
Financing | 100.17M | 372.46M | 6.6M | 311.3M | 16.28M |
Market Cap | 522.03M |
Price to Earnings Ratio | -2.42 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.01 |
Price to Book Ratio | 1.39 |
Dividend Yield | - |
Shares Outstanding | 61.42M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 2.25 (24.32%) |
Company Name | Replimune Group Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.replimune.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions